Skip to content

Gait and stance stability in cancer patients before and after rehabilitation

Gait and stance stability in cancer patients before and after rehabilitation - Go-Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00006253
Enrollment
60
Registered
2014-07-09
Start date
2014-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C81-C96

Interventions

Group 1: Dynamic postural control of patients after alloHCT or with Multiple Myeloma will be observed during their rehabilitation stay. The study-specific measurements include gait analysis and will b

Sponsors

Universtätsklinik FreiburgKlinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients after allogeneic stem cell transplantation patients with multiple myeloma Participation at the rehabilitation at the clinic of tumorbiology Freiburg Written informed consent of the patient

Exclusion criteria

Exclusion criteria: no written informed consent

Design outcomes

Primary

MeasureTime frame
gait stability (sec., m/s, Coefficient of variation%)

Secondary

MeasureTime frame
a - Questionnaire regarding side effects (score) b - Duration of hospitalization (days) c - Overall duration of the medical treatment after initial diagnosis (weeks) d - Questionnaire of activity behaviour before and since initial diagnosis (Score) e - Falls Efficacy Scale-International Version (FES-I) (Score)

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026